Home » Topics » Briefs » Other news to note

Other news to note
RSS

Halozyme Therapeutics licenses its Enhanze drug-delivery technology to Roche

Sep. 15, 2017

Otonomy announces financial and business update

Sep. 14, 2017

Merger between Inspyr Therapeutics and Lewis and Clark Pharmaceuticals completed

Sep. 14, 2017

Inotek enters merger agreement with Rocket Pharmaceuticals

Sep. 13, 2017

NeuroDerm gives update on proposed acquisition by Mitsubishi Tanabe Pharma

Sep. 13, 2017

HitGen and Takeda establish drug discovery research collaboration

Sep. 12, 2017

Bristol-Myers Squibb completes acquisition of IFM Therapeutics

Sep. 8, 2017

Alnylam updates status of fitusiran and givosiran development programs

Sep. 8, 2017

MacroGenics advances two bispecific DART product candidates

Sep. 6, 2017

Fresenius Kabi closes acquisition of Merck KGaA's biosimilars business

Sep. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...